Soluble type IIIL-1 decoy receptor: Reversal of autocrine and paracrine effects of IL-1 in human arthritis.

被引：0
|
作者：
Amin, AR
Attur, MG
Dave, MN
Cipolletta, C
Patel, IR
Abramson, SB
Kang, P
Goldring, MB
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1722
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [31] A truncated form of the soluble IL-1 receptor type I which binds IL-1ra but not IL-1 alpha or IL-1 beta.
    Caffes, P
    Anderson, LJ
    Vigers, GPA
    Brandhuber, BJ
    PROTEIN ENGINEERING, 1997, 10 : 81 - 81
  • [32] STRUCTURAL ASPECTS OF IL-1 BINDING TO THE TYPE-I HUMAN IL-1 RECEPTOR
    YOUNG, PR
    EINSTEIN, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 84 - 84
  • [33] The secretion of IL-1β by human melanoma cells acts as an autocrine and paracrine factor to promote tumor progression
    Okamoto, Miyako
    Tanaka, Aki
    Chan, Daniel C. F.
    Shellman, Yiqun G.
    Norris, David A.
    Dinarello, Charles A.
    Fujita, Mayumi
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 272 - 272
  • [34] INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4
    COLOTTA, F
    RE, F
    MUZIO, M
    BERTINI, R
    POLENTARUTTI, N
    SIRONI, M
    GIRI, JG
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    SCIENCE, 1993, 261 (5120) : 472 - 475
  • [35] Analysis of interleukin (IL)-Iβ IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders
    Libra, M
    Mangano, K
    Anzaldi, M
    Quattrocchi, C
    Donia, M
    Di Marco, R
    Signorelli, S
    Scalia, G
    Zignego, AL
    De Re, V
    Mazzarino, MC
    Nicoletti, F
    ONCOLOGY REPORTS, 2006, 15 (05) : 1305 - 1308
  • [36] Expression of IL-1β, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells:: Effects of all-trans-retinoic acid
    Wagsater, Dick
    Jatta, Ken
    Ocaya, Pauline
    Dimberg, Jan
    Sirsjo, Allan
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 (04) : 377 - 382
  • [37] SPECIFIC BINDING OF INTERLEUKIN-1 (IL-1)BETA AND IL-1 RECEPTOR ANTAGONIST (IL-1RA) TO HUMAN SERUM - HIGH-AFFINITY BINDING OF IL-1RA TO SOLUBLE IL-1 RECEPTOR TYPE-I
    SVENSON, M
    HANSEN, MB
    HEEGAARD, P
    ABELL, K
    BENDTZEN, K
    CYTOKINE, 1993, 5 (05) : 427 - 435
  • [38] IL-1 RECEPTOR ANTAGONIST IN ARTHRITIS AND ARTHRITIS MODELS
    THOMPSON, RC
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 : S169 - S169
  • [39] DIFFERENTIAL BINDING OF HUMAN INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST TO NATURAL AND RECOMBINANT SOLUBLE AND CELLULAR IL-1 TYPE-I RECEPTORS
    SVENSON, M
    NEDERGAARD, S
    HEEGAARD, PMH
    WHISENAND, TD
    AREND, WP
    BENDTZEN, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) : 2842 - 2850
  • [40] Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II
    Ruggiero, P
    Bossu, P
    Macchia, G
    DelGrosso, E
    Sabbatini, V
    Bertini, R
    Colagrande, A
    Bizzarri, C
    Maurizi, G
    DiCioccio, V
    DAndrea, G
    DiGiulio, A
    Frigerio, F
    Grifantini, R
    Grandi, G
    Tagliabue, A
    Boraschi, D
    JOURNAL OF IMMUNOLOGY, 1997, 158 (08): : 3881 - 3887
12345